Healthcare >> CEO Interviews >> July 8, 2002

Edward Lanphier Ii – Sangamo Biosciences Inc (sgmo)

EDWARD O. LANPHIER II, the Founder of Sangamo BioSciences, Inc., has served as President, Chief Executive Officer and a member of the Board of Directors since the company's inception. Mr. Lanphier has approximately 20 years of experience in the pharmaceutical and biotechnology industry. From June 1992 to May 1997, he held various positions at Somatix Therapy Corporation, a gene therapy company, including Executive Vice President, Commercial Development, and Chief Financial Officer. Prior to Somatix, Mr. Lanphier was President and Chief Executive Officer of BioGrowth, Inc., a biotechnology company that merged with Celtrix Laboratories to form Celtrix Pharmaceuticals, Inc., in 1991. From 1986 to 1987, Mr. Lanphier served as Vice President of Corporate Development at Biotherapeutics, Inc. From 1984 to 1986 he served as Vice President of Corporate Development at Synergen Inc. Prior to Synergen, he was employed by Eli Lilly and Company, a pharmaceutical company, in the strategic business planning-biotechnology group. Mr. Lanphier is a member of the Biotechnology Industry Organization (BIO) Emerging Companies Section and the BIO Board of Directors. Mr. Lanphier has a BA in Biochemistry from Knox College. Profile
TWST: Can we start out with an update? What has gone on at the company

over the past couple of quarters that investors should focus on?

Mr. Lanphier: There has been a lot of activity at